Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

RenovoRx (RNXT) Return on Sales (2025)

Historic Return on Sales for RenovoRx (RNXT) over the last 1 years, with Q3 2025 value amounting to 11.61%.

  • RenovoRx's Return on Sales changed N/A to 11.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.76%, marking a year-over-year change of. This contributed to the annual value of 246.19% for FY2024, which is N/A changed from last year.
  • Latest data reveals that RenovoRx reported Return on Sales of 11.61% as of Q3 2025.
  • In the past 5 years, RenovoRx's Return on Sales registered a high of 6.03% during Q2 2025, and its lowest value of 15.25% during Q1 2025.